Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis

被引：0
|
作者：
Gander-Bui, H.
Schafli, J.
Baumgartner, J.
Walthert, S.
Genitsch, V.
van Geest, G.
Galvan, J. A.
Cardozo, C.
Martinez, C. G.
Grans, M.
Bruggmann, R.
Probst, H. C.
Gabay, C.
Freigang, S.
Muth, S.
机构：
来源：
SWISS MEDICAL WEEKLY | 2023年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FC 15
引用
收藏
页码：4S / 4S
页数：1
相关论文
共 50 条
  • [31] THE INTERLEUKIN-1 RECEPTOR ANTAGONIST (RHIL-1RA) PROTECTS AGAINST CEREBRAL INFARCTION IN A RAT MODEL OF HYPOXIA-ISCHEMIA
    MARTIN, D
    CHINOOKOSWONG, N
    MILLER, G
    EXPERIMENTAL NEUROLOGY, 1994, 130 (02) : 362 - 367
  • [32] RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) - EFFECTIVE THERAPY AGAINST GRAM-NEGATIVE SEPSIS IN RATS
    ALEXANDER, HR
    DOHERTY, GM
    VENZON, DJ
    MERINO, MJ
    FRAKER, DL
    NORTON, JA
    SURGERY, 1992, 112 (02) : 188 - 194
  • [33] The interleukin-1 receptor antagonist anakinra protects from renal ischemia-reperfusion injury
    Rusai, Krisztina
    Huang, Hai
    Syed, Nora
    Strobl, Matthias
    Roos, Marcel
    Schmaderer, Christoph
    Heemann, Uwe
    Lutz, Jens
    TRANSPLANT INTERNATIONAL, 2007, 20 : 215 - 215
  • [34] EFFECT OF AN INTERLEUKIN-1 RECEPTOR ANTAGONIST ON THE HEMODYNAMIC MANIFESTATIONS OF GROUP-B STREPTOCOCCAL SEPSIS
    VALLETTE, JD
    GOLDBERG, RN
    SUGUIHARA, C
    DELMORAL, T
    MARTINEZ, O
    LIN, J
    THOMPSON, RC
    BANCALARI, E
    PEDIATRIC RESEARCH, 1995, 38 (05) : 704 - 708
  • [35] INTERLEUKIN-1 RECEPTOR ANTAGONIST PREVENTS SEPSIS-INDUCED INHIBITION OF PROTEIN-SYNTHESIS
    COONEY, R
    OWENS, E
    JURASINSKI, C
    GRAY, K
    VANNICE, J
    VARY, T
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1994, 267 (05): : E636 - E641
  • [36] Regulation of peptide-chain initiation in muscle during sepsis by interleukin-1 receptor antagonist
    Vary, TC
    Voisin, L
    Cooney, RN
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 271 (03): : E513 - E520
  • [37] Heterogeneous Treatment Effect Of Recombinant Human Interleukin-1 Receptor Antagonist For Human Severe Sepsis
    Meyer, N. J.
    Dunn, T. G.
    Reilly, J. P.
    Palakshappa, J. A.
    Feng, R.
    Christie, J. D.
    Palardy, J. E.
    Opal, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [38] INTERLEUKIN-1 PROTECTS AGAINST THE LETHAL EFFECTS OF IRRADIATION OF MICE BUT HAS NO EFFECT ON TUMORS IN THE SAME ANIMALS
    DORIE, MJ
    ALLISON, AC
    ZAGHLOUL, MS
    KALLMAN, RF
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1989, 191 (01): : 23 - 29
  • [39] Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas
    Ding, Yujie
    Yi, Jie
    Wang, Jinxin
    Sun, Zhida
    HELIYON, 2023, 9 (04)
  • [40] Is Interleukin-1 Receptor Blockade Ready for Prime Time in Patients With Severe Sepsis and Macrophage Activation Syndrome?
    Johnson, Daniel W.
    Kalil, Andre C.
    CRITICAL CARE MEDICINE, 2016, 44 (02) : 443 - 444
12345